Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 933527, "name": "Aarey Drugs", "stock_name": "Aarey Drugs", "full_name": "Aarey Drugs & Pharmaceuticals Ltd", "name_url": "stocks-analysis/aarey-drugs", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "63.84", "chg": 1.81, "chgp": "2.92%", "dir": 1, "prev_price": "62.03", "mcapval": "181.01 Cr", "mcap": "Micro Cap", "scripcode": 524412, "symbol": "AAREYDRUGS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 49, "indexname": "India SENSEX", "isin": "INE198H01019", "curr_date": "Mar 24", "curr_time": "", "bse_nse_vol": "64.12 k", "exc_status": "Active", "traded_date": "Mar 24, 2026", "traded_date_str": "2026 03 24", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarey-drugs-933527-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-ltd-is-rated-strong-sell-3909787", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AareyDrugsPharm_mojoScore_3909787.png", "date": "2026-03-24 10:10:16", "description": "Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 24 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook." }, { "title": "Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-ltd-is-rated-strong-sell-3886684", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/AareyDrugsPharm_mojoScore_3886684.png", "date": "2026-03-12 10:10:18", "description": "Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 12 March 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Aarey Drugs & Pharmaceuticals Ltd Falls 2.23%: Volatility and Circuit Hits Mark the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-falls-223-volatility-and-circuit-hits-mark-the-week-3862407", "imagepath": "", "date": "2026-02-28 14:01:22", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>23 Feb:</strong> Upper circuit hit at Rs.83.05 amid strong buying momentum</p>\n <p><strong>24 Feb:</strong> Lower circuit plunge to Rs.72.45 on heavy selling pressure</p>\n <p><strong>26 Feb:</strong> Upper circuit hit again at Rs.77.71 driven by renewed buying</p>\n <p><strong>27 Feb:</strong> Week closes at Rs.77.07, down 2.23%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.78.83</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">..." }, { "title": "Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-ltd-is-rated-strong-sell-3859763", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AareyDrugsPharm_mojoScore_3859763.png", "date": "2026-02-27 10:10:47", "description": "Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 February 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Aarey Drugs & Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3858079", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AareyDrugsPharm_stocks_hitting_upper_circuit_3858079.png", "date": "2026-02-26 11:00:07", "description": "Aarey Drugs & Pharmaceuticals Ltd witnessed a robust surge in its share price on 26 Feb 2026, hitting the upper circuit limit with an intraday gain of 8.31%, reflecting intense buying interest and a significant reversal after two days of decline. The stock outperformed its sector and broader market indices, signalling renewed investor confidence despite its recent strong sell rating." }, { "title": "Aarey Drugs & Pharmaceuticals Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-3853182", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AareyDrugsPharm_stocks_hitting_lower_circuit_3853182.png", "date": "2026-02-24 13:00:09", "description": "Shares of Aarey Drugs & Pharmaceuticals Ltd tumbled sharply on 24 Feb 2026, hitting the maximum permissible daily loss limit of 9.99% and closing at ₹72.45. The micro-cap pharmaceutical company faced intense selling pressure, with volumes surging and the stock underperforming its sector and broader market indices amid a wave of panic selling and unfilled supply." }, { "title": "Aarey Drugs & Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-momentum-3851324", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AareyDrugsPharm_stocks_hitting_upper_circuit_3851324.png", "date": "2026-02-23 10:00:26", "description": "Aarey Drugs & Pharmaceuticals Ltd witnessed a significant surge in its share price on 23 Feb 2026, hitting the upper circuit limit of 10% and closing at ₹83.05. This remarkable rally was driven by strong buying interest, sustained investor participation, and a notable gap-up opening, marking a continuation of the stock’s impressive five-day winning streak." }, { "title": "Aarey Drugs & Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/aarey-drugs-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3848024", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AareyDrugsPharm_stocks_hitting_upper_circuit_3848024.png", "date": "2026-02-20 10:00:22", "description": "Aarey Drugs & Pharmaceuticals Ltd witnessed a remarkable surge on 20 Feb 2026, hitting its upper circuit limit with a robust 7.86% gain, driven by intense buying interest and heightened volatility. The stock’s performance outpaced its sector and the broader market, reflecting renewed investor enthusiasm despite its current strong sell rating." }, { "title": "Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/aarey-drugs-pharmaceuticals-ltd-is-rated-strong-sell-3842216", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AareyDrugsPharm_mojoScore_3842216.png", "date": "2026-02-16 10:10:24", "description": "Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 November 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 16 February 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook." } ], "total": 569, "sid": "933527", "stock_news_url": "https://www.marketsmojo.com/news/aarey-drugs-pharmaceuticals-933527" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "14-Feb-2026", "details": "Newspaper Publication of the Unaudited Financial Results", "source": "BSE" }, { "caption": "Board Comments On The Fine Levied By The Exchange", "datetime": "12-Feb-2026", "details": "Board Comments on the fine levied by the Exchange", "source": "BSE" }, { "caption": "Unaudited Financial Results For The Quarter Ended 31St December 2025", "datetime": "11-Feb-2026", "details": "Approval of Unaudited Financial Results for the quarter ended 31st December 2025", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Aarey Drugs & Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 13 Dec 18", "dt": "2018-12-13", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>1:5</strong> bonus issue, ex-date: 25 Jun 12", "dt": "2012-06-25", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Aarey Drugs & Pharmaceuticals Ltd has announced <strong>2:1</strong> rights issue, ex-date: 19 Jan 12", "dt": "2012-01-19", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

23 Feb: Upper circuit hit at Rs.83.05 amid strong buying momentum

24 Feb: Lower circuit plunge to Rs.72.45 on heavy selling pressure

26 Feb: Upper circuit hit again at Rs.77.71 driven by renewed buying

27 Feb: Week closes at Rs.77.07, down 2.23%

Read full news article

Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell

2026-02-27 10:10:47

Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-02-26 11:00:07

Aarey Drugs & Pharmaceuticals Ltd witnessed a robust surge in its share price on 26 Feb 2026, hitting the upper circuit limit with an intraday gain of 8.31%, reflecting intense buying interest and a significant reversal after two days of decline. The stock outperformed its sector and broader market indices, signalling renewed investor confidence despite its recent strong sell rating.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure

2026-02-24 13:00:09

Shares of Aarey Drugs & Pharmaceuticals Ltd tumbled sharply on 24 Feb 2026, hitting the maximum permissible daily loss limit of 9.99% and closing at ₹72.45. The micro-cap pharmaceutical company faced intense selling pressure, with volumes surging and the stock underperforming its sector and broader market indices amid a wave of panic selling and unfilled supply.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Momentum

2026-02-23 10:00:26

Aarey Drugs & Pharmaceuticals Ltd witnessed a significant surge in its share price on 23 Feb 2026, hitting the upper circuit limit of 10% and closing at ₹83.05. This remarkable rally was driven by strong buying interest, sustained investor participation, and a notable gap-up opening, marking a continuation of the stock’s impressive five-day winning streak.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-02-20 10:00:22

Aarey Drugs & Pharmaceuticals Ltd witnessed a remarkable surge on 20 Feb 2026, hitting its upper circuit limit with a robust 7.86% gain, driven by intense buying interest and heightened volatility. The stock’s performance outpaced its sector and the broader market, reflecting renewed investor enthusiasm despite its current strong sell rating.

Read full news article

Aarey Drugs & Pharmaceuticals Ltd is Rated Strong Sell

2026-02-16 10:10:24

Aarey Drugs & Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 November 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 16 February 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article